2011, Pharmaceuticals and Self-awareness - Mental Health Clinicians

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2011

Pharmaceuticals

Self-awareness

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Four)

Mad in America

OCTOBER 30, 2023

As of mid-2011, despite over 100 papers having been published, 11 prespecified outcomes had still not been reported. of the patients, and the authors said that their study “provides new evidence to suggest little to no relation between use of a selective serotonin reuptake inhibitor and self-reported suicidal ideation.”

Pharmaceuticals

Pharmaceuticals Manufacturing Bipolar disorder Self-awareness

Part 4: Neurodiversity: New Paradigm, or Trojan Horse?

Mad in America

AUGUST 5, 2024

We consider the consequences of diagnosis as a form of social identity; of neurodivergence as a form of disability; and of self-diagnosis. Some of them self-identify as disabled, a category which—like neurodivergence itself—is extremely heterogenous. The consequences of ‘diagnosis as identity.’ Both outcomes are problematic.

Trauma and the brain

Trauma and the brain Genetics and mental health Self-awareness Personality disorders

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Four)

Part 4: Neurodiversity: New Paradigm, or Trojan Horse?

Stay Connected